Stevanato Group Spa(STVN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:00 PM ET (Korea 9/12 05:00)
Full metrics table
| Index | - | P/E | 36.34 | EPS (ttm) | 0.58 | Insider Own | 81.79% | Shs Outstand | 49.8M | Perf Week | 1.75% |
| Market Cap | 5.71B | Forward P/E | 24.57 | EPS next Y | 20.48% | Insider Trans | -0.01% | Shs Float | 49.7M | Perf Month | -1.65% |
| Enterprise Value | 6.12B | PEG | 1.43 | EPS next Q | 0.18 | Inst Own | 17.2% | Short Float | 2.26% | Perf Quarter | 20.88% |
| Income | 0.16B | P/S | 3.99 | EPS this Y | 12.62% | Inst Trans | -0.32% | Short Ratio | 2.92 | Perf Half Y | 42.76% |
| Sales | 1.43B | P/B | 3.22 | EPS next 5Y | 17.19% | ROA | 5.46% | Short Interest | 1.13M | Perf YTD | 3.88% |
| Book/sh | 6.49 | P/C | 63.46 | EPS past 3/5Y | 0.64% 11.33% | ROE | 9.2% | 52W High | -25.36% ($28.00) | Perf Year | -22.22% |
| Cash/sh | 0.33 | P/FCF | - | Sales past 3/5Y | 9% 12.15% | ROIC | 7.35% | 52W Low | 62.14% ($12.89) | Perf 3Y | -31.27% |
| Dividend Est. | $0.05 (0.22%) | EV/EBITDA | 17.62 | EPS Y/Y TTM | 7.43% | Gross Margin | 28.29% | Volatility(W/M) | 3.37% 3.49% | Perf 5Y | -21.28% |
| Dividend TTM | 0.06 | EV/Sales | 4.28 | Sales Y/Y TTM | 14.73% | Oper. Margin | 16.65% | ATR (14) | 0.76 | Perf 10Y | - |
| Dividend Ex-Date | 2026/6/11 | Quick Ratio | 1.08 | EPS Q/Q | -20.75% | Profit Margin | 10.99% | RSI (14) | 50.24 | Recom | 1.71 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.61 | Sales Q/Q | 10.63% | SMA20 | -2.15% ($21.36) | Beta | 0.78 | Target Price | $25.15 |
| Payout | 10.76% | Debt/Eq | 0.29 | Earnings | 2026/8/4 | SMA50 | 2.06% ($20.48) | Rel Volume | 2.3 | Prev Close | $20.95 |
| Employees | - | LT Debt/Eq | 0.21 | EPS/Sales Surpr. | 11.72% 2.18% | SMA200 | 14.18% ($18.3) | Avg Volume(3M) | 0.39M | Price | $20.9 |
| IPO | 2021/7/16 | Option/Short | Yes/Yes | Trades | 3999 | Volume | 885,736 | Change | -0.24% |
Company
STVN is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💉 This Italian company manufactures glass containers and drug delivery systems for the pharmaceutical and biotech industries. It supplies pharmaceutical firms with glass containers such as vials, syringes, and cartridges, as well as drug delivery devices including prefilled syringes and injection pens. As a medical device stock, its performance is closely tied to pharmaceutical production and injectable drug demand.
Over the past 1 year, roughly in the middle
25% below its 1-year high.
STVN makes money exceptionally well
16.65% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +12.6% this year.
Tap to view numbers
The price looks about right
Trading at 36.3 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -31.3% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.22% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 17.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
BCGD 0.02%
BCSM 0.02%
NBSM 0.01%
APPC 0.01%
XEUR 0.01%It ranks #4 in the industry
Based on market cap of $6B.
STVN $6B PER 36.3
ISRG $131B PER 42.4
BDX $48B PER 53.6
MDLN $43B PER 38.1
FAQ
What kind of company is STVN?
STVN belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of STVN?
The market cap of STVN is approximately $5.7B, ranking 1,289 within its sector.
Does STVN pay dividends?
STVN has a dividend yield of approximately 0.22%, with an annual dividend of $0.05.
What is the P/E ratio of STVN?
STVN has a P/E ratio of approximately 36.3x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for STVN?
STVN has recorded a 52-week high of $28.00 and a low of $12.89.
